Citation

Tallian KB, Nahata MC, Lo W, Tsao CY. Epilepsia 1996; 37(5): 501-502.

Affiliation

College of Pharmacy, Division of Neurology, Ohio State University, Columbus, USA.

Copyright

(Copyright © 1996, John Wiley and Sons)

DOI

unavailable

PMID

8617181

Abstract

Gabapentin (GBP) is a new antiepileptic drug (AED) approved for adjunctive treatment of complex partial seizures with or without seizures secondarily generalization in adults. We report 2 children who received GBP for intractable seizures and who developed intolerable aggressive behavior requiring dose reduction or drug discontinuation. Behavioral changes should be recognized as a possible side effect of GBP, especially in mentally retarded children.

Language: en